Incidence and clinical characteristics of myeloproliferative neoplasms displaying a PDGFRB rearrangement-Reference-Cited by-同舟云学术

Incidence and clinical characteristics of myeloproliferative neoplasms displaying a PDGFRB rearrangement

Published:2012-06-15 Issue:1 Volume:89 Page:37-41
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Arefi Maryam¹,García Juan L.²,Peñarrubia María J.¹,Queizán José A.³,Hermosín Lourdes⁴,López-Corral Lucía⁵,Megido Marta⁶,Giraldo Pilar⁷,Heras Natalia⁸,Vanegas Raúl J.⁹,Gutiérrez Norma C.⁵,Hernández-Rivas Jesús M.

Affiliation:

1. Servicio de Hematología; Hospital Clínico Universitario de Valladolid; Valladolid; Spain

2. Instituto de Ciencias de la Salud de Castilla y León (IESCYL); Salamanca; Spain

3. Servicio de Hematología; Hospital General de Segovia; Salamanca; Spain

4. Servicio de Hematología; Hospital del SAS; Jerez; Spain

5. Servicio de Hematología; Hospital Universitario de Salamanca; Salamanca; Spain

6. Servicio de Hematología; Hospital Camino de Santiago; Ponferrada; Spain

7. Servicio de Hematología; Hospital Miguel Servet; Zaragoza; Spain

8. Servicio de Hematología; Hospital Virgen Blanca; León; Spain

9. Servicio de Hematología; Hospital General de Ciudad Real; Ciudad Real; Spain

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2012.01799.x/fullpdf

Reference21 articles.

1. Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1;Tefferi;J Cell Mol Med,2009

2. Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organization criteria;Wadleigh;Int J Hematol,2010

3. The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos;Tefferi;Cancer,2009

4. Tyrosine Kinase fusion genes in chronic myeloproliferative disease;Cross;Leukemia,2002

5. Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor beta gene;Walz;Haematologica,2007

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel subclonal rearrangement of the STRN3::PDGFRB gene in de novo acute myeloid leukemia with NPM1 mutation and its leukemogenic effects;Cancer Gene Therapy;2023-08-07

2. Eosinophilia: hypereosinophilic syndrome vs. eosinophilic granulomatosis with polyangiitis;Zeitschrift für Rheumatologie;2023-04-26

3. A novel subclonal rearrangement of the STRN3::PDGFRB genes in de novo acute myeloid leukemia with NPM1 mutation and its leukemogenic effects;2023-03-23

4. Distinct and opposite effects of leukemogenic Idh and Tet2 mutations in hematopoietic stem and progenitor cells;Proceedings of the National Academy of Sciences;2023-01-18

5. La néoplasie myéloïde associée à un réarrangement de PDGFRB : une pathologie rare de diagnostic difficile;Annales de Pathologie;2022-11